• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Preclinical study on botulinum toxin therapy in treatment for neuropathic pain

Research Project

Project/Area Number 17K01358
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Biomedical engineering/Biomaterial science and engineering
Research InstitutionOkayama University

Principal Investigator

YAMAMOTO Yumiko  岡山大学, 医歯薬学総合研究科, 助教 (20403496)

Co-Investigator(Kenkyū-buntansha) 丸濱 功太郎  岡山大学, 医歯薬学総合研究科, 助教 (60712792)
松香 芳三  徳島大学, 大学院医歯薬学研究部(歯学域), 教授 (90243477)
Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywordsボツリヌス神経毒素 / 神経障害性疼痛 / SNAREタンパク質 / 細菌
Outline of Final Research Achievements

We have previously shown that botulinum toxin type A (BoNT/A) alleviates trigeminal neuropathy induced by infraorbital nerve constriction. In this study, we generated two rat models of chemotherapy-induced peripheral neuropathy, and assessed the analgesic effect of BoNT/A in chemotherapy-induced neuropathy. Unilateral BoNT/A administration into the whisker pad area attenuated chemotherapy-induced mechanical allodynia bilaterally.
In addition, we investigated the cleavage of synaptobrevin and syntaxin in the trigeminal ganglion neurons by botulinum toxin type B (BoNT/B) and by botulinum toxin type C (BoNT/C) respectively, to apply BoNT/B and BoNT/C to treatment for neuropathic pain.

Academic Significance and Societal Importance of the Research Achievements

日本人の2人に1人はがんになる時代において、抗がん薬による神経障害性疼痛で苦しむ患者さんは多い。これに対して有効な治療法はなく、抗がん薬の減量や化学療法の中止を余儀なくすることもある。本課題において、抗がん薬誘発性疼痛モデルラットでボツリヌス神経毒素の有効性を明らかにした。今後ボツリヌス神経毒素の作用機序を解明出来れば、詳細の分かっていない抗がん薬誘発性神経障害性疼痛発症機序の解明の一助になるとともに、ボツリヌス療法は抗がん薬誘発性神経障害性疼痛の治療においても期待できる。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (5 results)

All 2019 2018 2017

All Presentation (4 results) (of which Int'l Joint Research: 1 results) Book (1 results)

  • [Presentation] ボツリヌス神経毒素の三叉神経節での作用機構の解析2019

    • Author(s)
      山本由弥子、丸濱功太郎、松香芳三、美間健彦、後藤和義、Arief Waskitho、横田憲治、阪口義彦、松下治、小熊惠二
    • Organizer
      第92回日本細菌学会総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] Orofacial neuropathic pain rat models induced by chemotherapy drugs2019

    • Author(s)
      Arief Waskitho, Yumiko Yamamoto, Tsuyoshi Morita, Huijiao Yan, Resmi Raju, Masamitsu Oshima, Junhel Dalanon, Otto Baba, Yoshizo Matsuka
    • Organizer
      Tokushima University Bioscience Retreat
    • Related Report
      2019 Annual Research Report
  • [Presentation] Bilateral effects of unilateral administration of botulinum toxin A in chemotherapy induced neuropathy2019

    • Author(s)
      Arief Waskitho, Yumiko Yamamoto, Tsuyoshi Morita, Huijiao Yan, Resmi Raju, Masamitsu Oshima, Junhel Dalanon, Otto Baba, Yoshizo Matsuka
    • Organizer
      Dentisphere
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research
  • [Presentation] C型とD型ボツリヌス毒素変換ファージの解析2018

    • Author(s)
      阪口義彦、内山淳平、小椋義俊、後藤和義、山本由弥子、松崎茂展、山口明日美、林哲也、小熊惠二、林俊治
    • Organizer
      第91回日本細菌学会総会
    • Related Report
      2017 Research-status Report
  • [Book] 病原細菌・ウイルス図鑑(ボツリヌス菌)2017

    • Author(s)
      小熊惠二、鈴木智典、山本由弥子
    • Total Pages
      916
    • Publisher
      北海道大学出版会
    • ISBN
      9784832982291
    • Related Report
      2017 Research-status Report

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi